orphan drug

Biogen Idec is recruiting participants for its 'EMPOWER' trial, which will study the effects of the experimental treatment dexpramipexole in ALS

Posted on Thursday, March 31, 2011 - 05:30, By: Amy Madsen
Update 8/31/11: Enrollment screening for this study has closed to new prospective participants.
Posted on Saturday, May 1, 2010 - 11:54, By: ALSN Staff
Cytokinetics seeks participants for CK-2017357 study Cytokinetics, a South San Francisco biotechnology company, is seeking participants with ALS for a trial of its experimental compound CK-2017357.